Published • loading... • Updated
NIRSense Supports the US Army in the Indo-Pacific with Tissue Oxygenation Assessment for Battlefield Casualty Care at Balikatan-26
The company is testing portable StO2 monitoring with U.S. and Philippine forces to help medics improve triage and evacuation decisions.
- NIRSense, Inc. participated in Balikatan-26 on Saturday, supporting the Army Pacific's 18th Theater Medical Command as they evaluated portable tissue oxygen saturation monitoring for battlefield casualty assessment.
- Traditional vital signs often fail to capture local tissue compromise during extremity trauma or hemorrhage, creating a need for advanced hemodynamic tools in austere, distributed operational environments.
- "Balikatan-26 provides an important opportunity to work alongside operational medical teams," said Robert Furberg, PhD, TP-C of NIRSense. The platform equips combat medics with actionable data regarding perfusion.
- The technology provides non-invasive, real-time insights into tissue oxygen delivery at the point of injury, supporting triage, intervention, and evacuation decisions for warfighters.
- This effort builds on the company's broader mission to deliver ruggedized physiological monitoring, following the January 21, 2026 deployment of its systems for casualty care support in Ukraine.
Insights by Ground AI
37 Articles
37 Articles
NIRSense Supports the US Army in the Indo-Pacific with Tissue Oxygenation Assessment for Battlefield Casu
RICHMOND, Va., May 9, 2026 /PRNewswire/ -- NIRSense, Inc. today announced its participation in Balikatan-26, supporting the US Army Pacific (USARPAC)'s 18th Theater Medical Command (18th TMC) as they evaluate advanced approaches to battlefield casualty assessment using portable tissue oxygen saturation (StO₂) monitoring. Balikatan, meaning "shoulder-to-shoulder," is the longstanding U.S.-Philippine bilateral exercise designed to strengthen inte…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources37
Leaning Left3Leaning Right3Center17Last UpdatedBias Distribution74% Center
Bias Distribution
- 74% of the sources are Center
74% Center
13%
C 74%
13%
Factuality
To view factuality data please Upgrade to Premium
